Clinical Trial Update: Timing of Initiation of LMWH Administration in Pregnant Women With APS [Phase 4]

View source ↗

Summary

Phase 4 trial update on the optimal timing to initiate low molecular weight heparin in pregnant women with antiphospholipid syndrome. The condition is linked to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Pregnancy Loss

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Mohamed Sayed Abdelhafez | Conditions: Recurrent Miscarriage, Antiphospholipid Syndrome | Phase 4 | Status: COMPLETED